Isocitrate dehydrogenase (IDH) wildtype (wt) astrocytomas without the microscopic features of glioblastoma have high recurrence rates and were re-classified in the presence of certain molecular features as CNS WHO grade 4 tumors in the latest WHO classification of 2021. This evidence concerns the gene IDH1 and glioblastoma.